vs
SSR MINING INC.（SSRM）与Teladoc Health, Inc.（TDOC）财务数据对比。点击上方公司名可切换其他公司
Teladoc Health, Inc.的季度营收约是SSR MINING INC.的1.2倍（$642.3M vs $521.7M），SSR MINING INC.同比增速更快（61.4% vs 0.3%），SSR MINING INC.自由现金流更多（$106.4M vs $85.1M），过去两年SSR MINING INC.的营收复合增速更高（50.5% vs -0.3%）
SSR Mining Inc.（前身为白银标准资源公司）总部位于美国科罗拉多州丹佛，主营金、银、铜、铅、锌矿产开采，拥有阿根廷最大的银矿，同时在美洲全境及土耳其开展矿产勘探业务。2020年与阿拉瑟黄金合并后迁至丹佛，现任总裁兼首席执行官为罗德尼·P·安塔尔。
泰莱达克健康是一家跨国远程医疗与虚拟医疗企业，2002年成立，总部位于美国纽约。公司核心业务涵盖远程问诊、医学意见咨询、人工智能与数据分析、远程医疗设备及可授权平台服务，主要通过电话、视频会议软件与移动应用，为用户提供随时可及的远程医疗服务。
SSRM vs TDOC — 直观对比
营收规模更大
TDOC
是对方的1.2倍
$521.7M
营收增速更快
SSRM
高出61.2%
0.3%
自由现金流更多
SSRM
多$21.2M
$85.1M
两年增速更快
SSRM
近两年复合增速
-0.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $521.7M | $642.3M |
| 净利润 | $181.5M | — |
| 毛利率 | — | — |
| 营业利润率 | 38.8% | -5.6% |
| 净利率 | 34.8% | — |
| 营收同比 | 61.4% | 0.3% |
| 净利润同比 | 3166.6% | — |
| 每股收益（稀释后） | $0.84 | $-0.14 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收SSRMTDOC
| Q4 25 | $521.7M | $642.3M | ||
| Q3 25 | $385.8M | $626.4M | ||
| Q2 25 | $405.5M | $631.9M | ||
| Q1 25 | $316.6M | $629.4M | ||
| Q4 24 | $323.2M | $640.5M | ||
| Q3 24 | $257.4M | $640.5M | ||
| Q2 24 | $184.8M | $642.4M | ||
| Q1 24 | $230.2M | $646.1M |
净利润SSRMTDOC
| Q4 25 | $181.5M | — | ||
| Q3 25 | $65.4M | $-49.5M | ||
| Q2 25 | $90.1M | $-32.7M | ||
| Q1 25 | $58.8M | $-93.0M | ||
| Q4 24 | $5.6M | — | ||
| Q3 24 | $10.6M | $-33.3M | ||
| Q2 24 | $9.7M | $-837.7M | ||
| Q1 24 | $-287.1M | $-81.9M |
营业利润率SSRMTDOC
| Q4 25 | 38.8% | -5.6% | ||
| Q3 25 | 21.6% | -8.3% | ||
| Q2 25 | 26.9% | -8.6% | ||
| Q1 25 | 21.1% | -19.2% | ||
| Q4 24 | 10.6% | -7.5% | ||
| Q3 24 | 3.5% | -6.9% | ||
| Q2 24 | 5.8% | -130.9% | ||
| Q1 24 | -163.5% | -13.5% |
净利率SSRMTDOC
| Q4 25 | 34.8% | — | ||
| Q3 25 | 17.0% | -7.9% | ||
| Q2 25 | 22.2% | -5.2% | ||
| Q1 25 | 18.6% | -14.8% | ||
| Q4 24 | 1.7% | — | ||
| Q3 24 | 4.1% | -5.2% | ||
| Q2 24 | 5.2% | -130.4% | ||
| Q1 24 | -124.7% | -12.7% |
每股收益（稀释后）SSRMTDOC
| Q4 25 | $0.84 | $-0.14 | ||
| Q3 25 | $0.31 | $-0.28 | ||
| Q2 25 | $0.42 | $-0.19 | ||
| Q1 25 | $0.28 | $-0.53 | ||
| Q4 24 | $0.03 | $-0.27 | ||
| Q3 24 | $0.05 | $-0.19 | ||
| Q2 24 | $0.05 | $-4.92 | ||
| Q1 24 | $-1.42 | $-0.49 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $575.6M | $781.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $3.5B | $1.4B |
| 总资产 | $6.1B | $2.9B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资SSRMTDOC
| Q4 25 | $575.6M | $781.1M | ||
| Q3 25 | $445.4M | $726.2M | ||
| Q2 25 | $438.5M | $679.6M | ||
| Q1 25 | $341.3M | $1.2B | ||
| Q4 24 | $417.3M | $1.3B | ||
| Q3 24 | $365.8M | $1.2B | ||
| Q2 24 | $384.4M | $1.2B | ||
| Q1 24 | $492.0M | $1.1B |
总债务SSRMTDOC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $228.6M | — | ||
| Q3 24 | $228.3M | — | ||
| Q2 24 | $228.0M | — | ||
| Q1 24 | $228.7M | — |
股东权益SSRMTDOC
| Q4 25 | $3.5B | $1.4B | ||
| Q3 25 | $3.3B | $1.4B | ||
| Q2 25 | $3.3B | $1.4B | ||
| Q1 25 | $3.2B | $1.4B | ||
| Q4 24 | $3.1B | $1.5B | ||
| Q3 24 | $3.1B | $1.5B | ||
| Q2 24 | $3.1B | $1.5B | ||
| Q1 24 | $3.1B | $2.3B |
总资产SSRMTDOC
| Q4 25 | $6.1B | $2.9B | ||
| Q3 25 | $5.9B | $2.9B | ||
| Q2 25 | $5.8B | $2.9B | ||
| Q1 25 | $5.6B | $3.4B | ||
| Q4 24 | $5.2B | $3.5B | ||
| Q3 24 | $5.1B | $3.5B | ||
| Q2 24 | $5.2B | $3.5B | ||
| Q1 24 | $5.3B | $4.3B |
负债/权益比SSRMTDOC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.07× | — | ||
| Q3 24 | 0.07× | — | ||
| Q2 24 | 0.07× | — | ||
| Q1 24 | 0.07× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $172.1M | $87.7M |
| 自由现金流经营现金流 - 资本支出 | $106.4M | $85.1M |
| 自由现金流率自由现金流/营收 | 20.4% | 13.3% |
| 资本支出强度资本支出/营收 | 12.6% | 0.4% |
| 现金转化率经营现金流/净利润 | 0.95× | — |
| 过去12个月自由现金流最近4个季度 | $241.6M | $285.5M |
8季度趋势，按日历期对齐
经营现金流SSRMTDOC
| Q4 25 | $172.1M | $87.7M | ||
| Q3 25 | $57.2M | $99.3M | ||
| Q2 25 | $157.8M | $91.4M | ||
| Q1 25 | $84.8M | $15.9M | ||
| Q4 24 | $95.0M | $85.9M | ||
| Q3 24 | $-1.3M | $110.2M | ||
| Q2 24 | $-78.1M | $88.7M | ||
| Q1 24 | $24.6M | $8.9M |
自由现金流SSRMTDOC
| Q4 25 | $106.4M | $85.1M | ||
| Q3 25 | $-2.4M | $97.0M | ||
| Q2 25 | $98.4M | $90.2M | ||
| Q1 25 | $39.3M | $13.2M | ||
| Q4 24 | $56.4M | $79.8M | ||
| Q3 24 | $-34.1M | $108.6M | ||
| Q2 24 | $-116.3M | $86.8M | ||
| Q1 24 | $-9.4M | $7.8M |
自由现金流率SSRMTDOC
| Q4 25 | 20.4% | 13.3% | ||
| Q3 25 | -0.6% | 15.5% | ||
| Q2 25 | 24.3% | 14.3% | ||
| Q1 25 | 12.4% | 2.1% | ||
| Q4 24 | 17.5% | 12.5% | ||
| Q3 24 | -13.2% | 17.0% | ||
| Q2 24 | -62.9% | 13.5% | ||
| Q1 24 | -4.1% | 1.2% |
资本支出强度SSRMTDOC
| Q4 25 | 12.6% | 0.4% | ||
| Q3 25 | 15.4% | 0.4% | ||
| Q2 25 | 14.7% | 0.2% | ||
| Q1 25 | 14.4% | 0.4% | ||
| Q4 24 | 11.9% | 1.0% | ||
| Q3 24 | 12.7% | 0.2% | ||
| Q2 24 | 20.7% | 0.3% | ||
| Q1 24 | 14.8% | 0.2% |
现金转化率SSRMTDOC
| Q4 25 | 0.95× | — | ||
| Q3 25 | 0.87× | — | ||
| Q2 25 | 1.75× | — | ||
| Q1 25 | 1.44× | — | ||
| Q4 24 | 17.10× | — | ||
| Q3 24 | -0.13× | — | ||
| Q2 24 | -8.06× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
SSRM
| Gold | $369.3M | 71% |
| Concentrate Sales | $124.4M | 24% |
| Other | $19.1M | 4% |
| Lead | $9.0M | 2% |
TDOC
| Teladoc Health Integrated Care | $409.1M | 64% |
| Better Help | $233.2M | 36% |
